Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Opiant Pharmaceuticals Inc (OTCQB:OPNT)

8.50
Delayed Data
As of 1:24pm ET
 0.00 / 0.00%
Today’s Change
5.01
Today|||52-Week Range
11.75
+51.52%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues6.9M2.6M312.5K1.1M
 
 
 
 
 
Depreciation And Amortization343.00501.001.2K1.3K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses2.9M2.2M1.5M1.7M
 
 
 
 
 
Research And Development373.1K1.1M--441.8K
 
 
 
 
Total Operating Expenses2.9M2.2M1.5M1.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income4.0M411.9K-1.2M-579.0K
 
 
 
 
 
Interest Expense On Debt5.5K0.00571.002.2K
 
 
 
 
Other Expenses-25.8K4.3K-39.0K-19.4K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income4.0M416.1K-1.1M-600.6K
 
 
 
 
 
Net Income4.0M416.1K-1.1M-600.6K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.9M1.9M2.0M2.0M
 
 
 
 
 
Shares To Calculate EPS Diluted2.6M2.7M2.0M2.0M
 
 
 
 
 
 
Earnings Per ShareEPS$1.52$0.15-$0.52-$0.30
 
 
 
 
 
EPS Diluted$1.52$0.15-$0.55-$0.30